Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Yasuo Mori Last modified date:2022.06.22

Assistant Professor / Hematology, Oncology & Cardiovascular medicine / Kyushu University Hospital


Papers
1. Mori Y, Harada T, Yoshimoto G, Shima T, Numata A, Jinnouchi F, Yamauchi T, Kikushige Y, Kunisaki Y, Kato K, Takenaka K, Akashi K, Miyamoto T.1. Risk factors for late cytomegalovirus infection after completing letermovir prophylaxis., Risk factors for late cytomegalovirus infection after completing letermovir prophylaxis., Int J Hematol. , 2022.05.
2. Jinnouchi F, Mori Y, Yoshimoto G, Yamauchi T, Nunomura T, Yurino A, Hayashi M, Yuda J, Shima T, Odawara J, Takashima S, Kamezaki K, Kato K, Miyamoto T, Akashi K, Takenaka K., Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation., Int J Hematol. , 115, 1, 96-106, 2022.01.
3. Suetsugu K, Muraki S, Fukumoto J, Matsukane R, Mori Y, Hirota T, Miyamoto T, Egashira N, Akashi K, Ieiru I. , Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study. , Drugs in R & D., 21, 4, 419-429, 2021.04.
4. Miyawaki K, Kato K, Sugio T, Sasaki K, Miyoshi H, Semba Y, Kikushige Y, Mori Y, Kunisaki Y, Iwasaki H, Miyamoto T, Kuo FC, Aster JC, Ohshima K, Maeda T, Akashi K., A Germinal Center-Associated Microenvironmental Signature Reflects Malignant Phenotype and Outcome of DLBCL, Blood Adv., 6, 7, 2388-2402, 2022.06.
5. Yoshimoto G, Mori Y, Kato K, Odawara J, Kuriyama T, Ueno T, Obara T, Yurino A, Yoshida S, Ogawa R, Ohno Y, Iwasaki H, Eto T, Akashi K, Miyamoto T., Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation., Leuk Lymphoma, 2021.06.
6. Kanda Y, Inoue M, Uchida N, Onishi Y, Kamata R, Kotaki M, Kobayashi R, Tanaka J, Fukuda T, Fujii N, Miyamura K, Mori SI, Mori Y, Morishima Y, Yabe H, Kodera Y., Cryopreservation of unrelated hematopoietic stem cells from a blood and marrow donor bank during the COVID-19 pandemic. A nationwide survey by the Japan Marrow Donor Program., Transplant Cell Ther. , 2021.05.
7. Mori Y, Jinnouchi F, Takenaka K, Aoki T, Kuriyama T, Kadowaki M, Odawara J, Ueno T, Kohno K, Harada T, Yoshimoto G, Takase K, Henzan H, Kato K, Ito Y, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Akashi K, Miyamoto T., Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data., Bone Marrow Transplant., 2021.04.
8. Harada T, Iwasaki H, Muta T, Urata S, Sakamoto A, Kohno K, Takase K, Miyamura T, Sawabe T, Asaoku H, Oryoji K, Fujisaki T, Mori Y, Yoshimoto G, Ayano M, Mitoma H, Miyamoto T, Niiro H, Yamamoto H, Oshiro Y, Miyoshi H, Ohshima K, Takeshita M, Akashi K, Kato K., Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs., Br J Haematol., 2021.04.
9. Mori Y, Sasaki K, Ito Y, Kuriyama T, Ueno T, Kadowaki M, Aoki T, Sugio T, Yoshimoto G, Kato K, Maeda T, Nagafuji K, Akashi K, Miyamoto T., Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study., Ann Hematol., 2021.01.
10. Travaglini KJ, Nabhan AN, Penland L, Sinha R, Gillich A, Sit RV, Chang S, Conley SD, Mori Y, Seita J, Berry GJ, Shrager JB, Metzger RJ, Kuo CS, Neff N, Weissman IL, Quake SR, Krasnow MA., A molecular cell atlas of the human lung from single-cell RNA sequencing., Nature, 2020.11.
11. Ishiyama K, Nakao S, Usuki K, Yonemura Y, Ikezoe T, Uchiyama M, Mori Y, Fukuda T, Okada M, Fujiwara S, Noji H, Rottinghaus S, Aguzzi R, Yokosawa J, Nishimura JI, Kanakura Y, Okamoto S., Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients., Int J Hematol., 112, 4, 466-476, 2020.10.
12. Henzan H, Takase K, Kamimura T, Mori Y, Yoshimoto G, Iwasaki H, Nagafuji K, Ogawa R, Eto T, Uchida N, Fujisaki T, Kato K, Minami M, Kikushige Y, Akashi K, Miyamoto T; Fukuoka Blood & Marrow Transplantation Group (FBMTG)., Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy., Int J Hematol., 112, 3, 349-360, 2020.09.
13. Oku S, Takeshita T, Futatsuki T, Kageyama S, Asakawa M, Mori Y, Miyamoto T, Hata J, Ninomiya T, Kashiwazaki H., Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation., PLoS Pathogens, 2020.06.
14. Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T., Current status and needs of long-term follow-up clinics for hematopoietic cell transplant survivors: results of a nationwide survey in Japan., Biol Blood Marrow Transplant., 2020.05.
15. Ishida S, Morikawa H, Watanabe H, Tsuji T, Sugio T, Mori Y, Miyamoto T, Masuda S, Akashi K, Egashira N., Increasing diluent volume decreases bendamustine-induced venous irritation without reducing the therapeutic efficacy., Biol Pharm Bull., 43, 3, 488-492, 2020.03.
16. Mori Y, Choi I, Yoshimoto G, Muta T, Yamasaki S, Tanimoto K, Kamimura T, Iwasaki H, Ogawa R, Akashi K, Miyamoto T; Fukuoka Blood and Marrow Transplantation Group., Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma., Int J Hematol. , 2020.01.
17. Kodama T, Kochi Y, Nakai W, Mizuno H, Baba T, Habu K, Sawada N, Tsunoda H, Shima T, Miyawaki K, Kikushige Y, Mori Y, Miyamoto T, Maeda T, Akashi K., Anti-GPRC5D/CD3 bispecific T cell-redirecting antibody for the treatment of multiple myeloma., Mol Cancer Ther. , 18, 9, 1555-1564, 2019.09.
18. Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, Akashi K, Masuda S., Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation., Int J Mol Sci. , 2019.05.
19. Aoki T, Kamimura T, Yoshida S, Mori Y, Kadowaki M, Kohno K, Ishihara D, Urata S, Sugio T, Kamezaki K, Kato K, Ito Y, Eto T, Akashi K, Miyamoto T., Safety and seropositivity after live attenuated vaccine in adult patients receiving hematopoietic stem cell transplantation., Biol Blood Marrow Transplant., 2019.04.
20. Minami M, Matsushima T, Mori Y, Ishihara D, Jinnnouchi F, Takenaka K, Henzan T, Yoshimoto G, Numata A, Kato K, Maeda T, Miyamoto T, Akashi K., Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody., Bone Marrow Transplant., 2019.02.
21. Yoshimoto G, Mori Y, Kato K, Shima T, Miyawaki K, Kikushige Y, Kamezaki K, Numata A, Maeda T, Takenaka K, Iwasaki H, Teshima T, Akashi K, Miyamoto T., Human Herpes Virus-6-Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor-Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients., Biol Blood Marrow Transplant., 2018.12.
22. Zhu F, Feng M, Sinha R, Seita J, Mori Y, Weissman IL., Screening for genes that regulate the differentiation of human megakaryocytic lineage cells., Proc Natl Acad Sci U S A., 2018.10.
23. Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, Takenaka K, Iwasaki H, Shimono N, Akashi K, Miyamoto T. , Gastrointestinal graft-versus-host disease is a risk factor for
post-engraftment blood stream infection in allogeneic hematopoietic stem cell transplant recipients.
, Biol Blood Marrow Transplant., 2018.06.
24. Mori Y, Yoshimoto G, Yuda JI, Hayashi M, Odawara J, Kuriyama T, Sugio T, Miyawaki K, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K. , Previous exposure to bortezomib is linked to a lower risk of engraftment
syndrome after autologous hematopoietic stem cell transplantation.
, Leuk Lymphoma., 2018.05.
25. Sasaki K, Mori Y, Yoshimoto G, Sakoda T, Kato K, Inadomi K, Kamezaki K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K. , Successful treatment of Ph ALL with hematopoietic stem cell transplantation
from the same HLA-haploidentical related donor of previous liver transplantation.
, Leuk Lymphoma., 2017.11.
26. Miyawaki K, Iwasaki H, Jiromaru T, Kusumoto H, Yurino A, Sugio T, Uehara Y, Odawara J, Daitoku S, Kunisaki Y, Mori Y, Arinobu Y, Tsuzuki H, Kikushige Y, Iino T, Kato K, Takenaka K, Miyamoto T, Maeda T, Akashi K., Identification of unipotent megakaryocyte progenitors in human hematopoiesis., Blood. , 129, 25, 3332-3343, 2017;129(25):3332-3343., 2017.07.
27. Tsuzuki H, Arinobu Y, Miyawaki K, Takaki A, Ota SI, Ota Y, Mitoma H, Akahoshi M, Mori Y, Iwasaki H, Niiro H, Tsukamoto H, Akashi K., Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes., Immunology. , 2017;150(1):64-73., 2017.07.
28. Mori Y, Ikeda K, Inomata T, Yoshimoto G, Fujii N, Ago H, Teshima T., Ruxolitinib treatment for GvHD in patients with myelofibrosis., Bone Marrow Transplant. , 2016;51(12):1584-1587. , 2016.12.
29. Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Ogawa R, Ohno Y, Eto T, Kamimura T, Miyamoto T, Akashi K., Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease., Biol Blood Marrow Transplant. , 2016;22(9):1608-1614., 2016.09.
30. Mori Y, Chen JY, Pluvinage JV, Seita J, Weissman IL., Prospective isolation of human erythroid lineage-committed progenitors., Proc Natl Acad Sci U S A. , 112, 31, 9638-9643, 2015 Aug 4;112(31):9638-43., 2015.08.
31. Ho CC, Guo N, Sockolosky JT, Ring AM, Weiskopf K, Özkan E, Mori Y, Weissman IL, Garcia KC., "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis., J Biol Chem., 2015.05.
32. Miyanishi M, Mori Y*, Seita J, Chen JY, Karten S, Chan CK, Nakauchi H, Weissman IL., Do pluripotent stem cells exist in adult mice as very small embryonic stem cells?, Stem Cell Reports., 2013.07.
33. Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, Henzan H, Numata A, Ito Y, Takenaka K, Iwasaki H, Kamimura T, Eto T, Nagafuji K, Teshima T, Kato K, Akashi K., Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation., Blood, 2013.01.
34. Mori Y, Teshima T, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Miyamoto T, Nagafuji K, Eto T, Akashi K. , Validation of pretransplantation assessment of mortality risk score in the
outcome of hematopoietic SCT in non-Caucasians.
, Bone Marrow Transplant. , 47, 8, 1075-1081, 2012.08.
35. Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S, Takenaka K, Iwasaki H, Harada N, Shiratsuchi M, Abe Y, Nagafuji K, Teshima T, Akashi K. , Different risk factors related to adenovirus- or BK virus-associated
hemorrhagic cystitis following allogeneic stem cell transplantation.
, Biol Blood Marrow Transplant., 18, 3, 458-465, 2012.03.
36. Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K., Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia., Cancer Cell., 2011.08.
37. Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N, Kato K, Takenaka K, Iwasaki H, Harada N, Abe Y, Teshima T, Akashi K. , High incidence of human herpes virus 6-associated encephalitis/myelitis
following a second unrelated cord blood transplantation.
, Biol Blood Marrow Transplant., 16, 11, 1596-1602, 2010.11.
38. Mori Y, Nagasaki Y, Kamezaki K, Takenaka K, Iwasaki H, Harada N, Miyamoto T, Abe Y, Shimono N, Akashi K, Teshima T , High incidence of false-positive Aspergillus galactomannan test in multiple myeloma.
, Am J Hematol., 85, 6, 449-451, 2010.06.
39. Yamauchi T, Mori Y, Miyamoto T, Kamezaki K, Aoki T, Yamamoto A, Takenaka K, Iwasaki H, Harada N, Nagafuji K, Teshima T, Akashi K., Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia., Int J Hematol. , 2009.10.
40. Mori Y, Iwasaki H, Kohno K, Yoshimoto G, Kikushige Y, Okeda A, Uike N, Niiro H, Takenaka K, Nagafuji K, Miyamoto T, Harada M, Takatsu K, Akashi K. , Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor., J Exp Med. , 206, 1, 183-193, 2009;206(1):183-93. , 2009.01.
41. Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M., Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation., Eur J Haematol. , 2007.07.
42. Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, Shigematsu H, Takatsu K, Tenen DG, Akashi K., The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages., Genes Dev. , 2006.11.